Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO

NCT ID: NCT00199472

Last Updated: 2017-08-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Completion Date

2001-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Renal blood flow is inversely related to obstruction. We propose that this imaging will be as effective as the diuretic renogram in the functional diagnosis of obstruction. Furthermore, dynamic contrast CT scanning may also add anatomic information necessary for the surgical treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ureteral Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic Contrast Enhanced CT & Diuretic Renogram

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older;
* Subjects suspected to have UPJO.

Exclusion Criteria

* Pregnancy;
* Renal failure (Creatinine \>150);
* Allergy to contrast material;
* Ureteral stent;
* Nephrostomy tube;
* Renal pelvis calculi.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Joseph's Health Care London

OTHER

Sponsor Role collaborator

General Electric

INDUSTRY

Sponsor Role collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John D Denstedt, MD, FRCSC

Role: PRINCIPAL_INVESTIGATOR

Urology, St. Joseph's Hospital, University of Western Ontario

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Urology Clinic, St. Joseph's Hospital, St. Joseph's Health Care London

London, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07378

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OneShot Renal Denervation Registry
NCT01844037 TERMINATED PHASE2/PHASE3
Distal Renal Denervation
NCT02667912 COMPLETED NA
FGF19 and Chronic Kidney Disease
NCT04896047 RECRUITING NA